Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer treatment and survivorship statistics, 2016

(2016) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer

(2016) Fuquan Zhang et al.   CANCER SCIENCE

Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer

(2016) D.A. Fennell et al.   CANCER TREATMENT REVIEWS

Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms

(2016) L Wang et al.   Cell Death & Disease

Phase I study evaluating the safety and efficacy of oral panobinostat in combination with radiotherapy or chemoradiotherapy in patients with inoperable stage III non-small-cell lung cancer

(2015) Harminder S. Takhar et al.   ANTI-CANCER DRUGS

Tribbles in normal and malignant haematopoiesis

(2015) S. J. Stein et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Pseudokinase Tribbles 1 (TRB1) Negatively Regulates Tumor-Suppressor Activity of p53 through p53 Deacetylation

(2015) Chiharu Miyajima et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update

(2015) Naoko Takebe et al.   Nature Reviews Clinical Oncology

Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells

(2015) Amit Kumar Srivastava et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms

(2015) Monica Cojoc et al.   SEMINARS IN CANCER BIOLOGY

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

(2015) Zhen Ning Wee et al.   Nature Communications

Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach

(2015) Lihui Wang et al.   Oncotarget

Inhibition of tribbles protein-1 attenuates radioresistance in human glioma cells

(2015) Bo Tang et al.   Scientific Reports

Nucleotide excision repair: Why is it not used to predict response to platinum-based chemotherapy?

(2014) Nikola A. Bowden   CANCER LETTERS

TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression

(2014) Tetsuo Mashima et al.   CANCER RESEARCH

Concise Reviews: Cancer Stem Cells: From Concept to Cure

(2014) K. B. Matchett et al.   STEM CELLS

The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance

(2013) Radosław Januchowski et al.   BIOMEDICINE & PHARMACOTHERAPY

Dachshund Binds p53 to Block the Growth of Lung Adenocarcinoma Cells

(2013) K. Chen et al.   CANCER RESEARCH

MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1

(2013) Zhuo-Yuan Lin et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of C/EBPβ Target Genes in ALK+ Anaplastic Large Cell Lymphoma (ALCL) by Gene Expression Profiling and Chromatin Immunoprecipitation

(2013) Irina Bonzheim et al.   PLoS One

Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells

(2011) Roser Francisco et al.   CANCER LETTERS

Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells

(2011) Alba Pérez-Perarnau et al.   Epigenetics

Cancer Stem Cells and Side Population Cells in Breast Cancer and Metastasis

(2011) Kelly M. Britton et al.   Cancers

Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis

(2010) T. Yokoyama et al.   BLOOD

Metastatic potential of tumor-initiating cells in solid tumors

(2010) Amit et al.   Frontiers in Bioscience-Landmark

Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics

(2010) Anna Maria Calcagno et al.   JNCI-Journal of the National Cancer Institute

Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs

(2009) Vasundhra Kashyap et al.   STEM CELLS AND DEVELOPMENT

Cancer Stem Cells and the Ontogeny of Lung Cancer

(2008) Craig D. Peacock et al.   JOURNAL OF CLINICAL ONCOLOGY